Julie Lorent
Impact in
Papers in
-
- RNA Research and Splicing 2
- RNA and protein synthesis mechanisms 2
- RNA modifications and cancer 2
- Oncology 4
- Co-authors
- Maria De Santis (1 shared paper)Graham M. Mead (1 shared paper)Iwona Skoneczna (1 shared paper)Sandra Collette (1 shared paper)Pablo Maroto (1 shared paper)Richard Sylvester (1 shared paper)Gedske Daugaard (1 shared paper)Joaquim Bellmunt (1 shared paper)
- Journals
- Nucleic Acids Research (2 papers)Journal of Clinical Oncology (1 paper)Statistical Applications in Genetics and Molecular Biology (1 paper)Blood (1 paper)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (1 paper)
- Partner nations
- SwedenCanadaUnited States
In The Last Decade
Julie Lorent
16 papers receiving 994 citations
Julie Lorent's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 309
- Surgery 488
- Immunology 177
- Cancer Research 78
- Urology 19
Countries citing papers authored by Julie Lorent
This map shows the geographic impact of Julie Lorent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Lorent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Lorent more than expected).
Fields of papers citing papers by Julie Lorent
This network shows the impact of papers produced by Julie Lorent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Lorent. The network helps show where Julie Lorent may publish in the future.
Co-authors
The 25 scholars most cited alongside Julie Lorent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 Hit paper breakdown → | 2011 | 536 |
| 2 | 2016 | 123 | |
| 3 | 2019 | 53 | |
| 4 | 2017 | 48 | |
| 5 | 2015 | 42 | |
| 6 | 2018 | 37 | |
| 7 | 2011 | 29 | |
| 8 | 2014 | 22 | |
| 9 | 2018 | 22 | |
| 10 | 2018 | 21 | |
| 11 | 2020 | 21 | |
| 12 | 2017 | 18 | |
| 13 | 2015 | 16 | |
| 14 | 2009 | 11 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 1 |
About Julie Lorent
Julie Lorent is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Epidemiology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), RNA Research and Splicing (2 papers), RNA and protein synthesis mechanisms (2 papers), RNA modifications and cancer (2 papers), Trypanosoma species research and implications (1 paper), Dermatologic Treatments and Research (1 paper) and Mathematical Biology Tumor Growth (1 paper). The work is most often cited by research in Oncology (309 citations), Surgery (488 citations), Immunology (177 citations), Cancer Research (78 citations) and Urology (19 citations). Julie Lorent has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Maria De Santis, Graham M. Mead, Iwona Skoneczna, Sandra Collette, Pablo Maroto, Richard Sylvester, Gedske Daugaard, Joaquim Bellmunt, Michael Leahy and Ronald de Wit. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology, Statistical Applications in Genetics and Molecular Biology, Blood and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.